PDF) QUANTIFICATION OF ANTICOAGULANTS DABIGATRAN, RIVAROXABAN, AND PRASUGREL BY CHROMATOGRAPHIC AND SPECTROMETRIC TECHNIQUES – REVIEW
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study | Scientific Reports
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
Office of Clinical Parmacology Review (XARELTO)
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation - Clinical Therapeutics
Therapeutic Monitoring of Rivaroxaban in Dogs Using Thromboelastography and Prothrombin Time
Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban
Assessment of Dose Proportionality of Rivaroxaban Nanocrystals | SpringerLink
Pharmaceutics | Free Full-Text | The Development and Optimization of Hot-Melt Extruded Amorphous Solid Dispersions Containing Rivaroxaban in Combination with Polymers
Office of Clinical Parmacology Review (XARELTO)
RBCP - Cost comparison between enoxaparin and new oral anticoagulants dabigatran and rivaroxaban in venous thromboembolism prophylaxis
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
Top heart doctors fret over new blood thinners | Fox News
Edoxaban switching scheme: worth the risks? - The Pharmaceutical Journal
Office of Clinical Parmacology Review (XARELTO)
Office of Clinical Parmacology Review (XARELTO)
Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time - Bae - 2019 - Journal of Veterinary Internal Medicine - Wiley Online Library
Office of Clinical Parmacology Review (XARELTO)
Pradaxa And Xarelto: Top Heart Doctors Concerned Over New Blood Thinners | HuffPost Life
Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety
Comparative study of boron-doped diamond, basal-plane pyrolytic graphite, and graphite flake paste electrodes for the voltammetric determination of rivaroxaban and dabigatran etexilate in pharmaceuticals and urine samples - ScienceDirect
Assessment of Dose Proportionality of Rivaroxaban Nanocrystals | SpringerLink
Management guideline for bleeding while taking dabigatran, rivaroxaban... | Download Scientific Diagram
